Table 4.
Parameters | control negative (G1) |
CGB (G2) |
AFB1 (G3) |
AFG1 (G4) |
CGB + AFB1 (G5) |
CGB + AFG1 (G6) |
---|---|---|---|---|---|---|
CHL (mg/dL) |
88.37 ± 7.1c | 90.61 ± 4.9c | 73.4 ± 3.1a | 77.4 ± 2.4a | 80.1 ± 3.2b | 81.8 ± 2.5b |
TG (mg/dL) |
85.1 ± 1.73d | 85.7 ± 2.42d | 184.5 ± 3.61a | 163.1 ± 4.45a | 119.03 ± 3.42b | 105.1 ± 3.81c |
LDL-c (mg/dL) |
55.4 ± 3.1d | 55.2 ± 4.2d | 102.1 ± 3.4a | 91.6 ± 3.2a | 73.4 ± 2.1b | 62.1 ± 3.7c |
HDL-c (mg/dL) |
32.5 ± 1.3d | 32.3 ± 1.5d | 89.7 ± 2.3a | 86.4 ± 4.1a | 43.9 ± 3.7b | 39.6 ± 3.3c |
VLDL-c (mg/dL) |
17.08 ± 1.64d | 17.14 ± 1.73d | 36.9 ± 1.72a | 33.62 ± 1.89a | 23.8 ± 1.68b | 21.02 ± 1.76c |
● CHL: cholesterol; TG: triglycerides; LDL-c: low-density lipoproteins; HDL-c: high-density lipoproteins; VLDL-c: very low-density lipoproteins.
● Data expressed as means ± SD; (n = 3, P>0.05) –; CGB: Cape-golden berry.
● Rats of aflatoxins treated groups were orally administrated by dose of 850 ng/kg body weight/day.
● The data in the same raw shared the superscriptions had no significant differences.